Biotechnology Stocks Break out to Leadership Position with Growth
Biotechnology Leadership with Strong Growth and Earnings IBB is 28.94% YTD and 4.74% week to date.; XBI is up 27.94% YTD and 4.31% WTD. But off highs for year. ARKG genomics is up 6.73% WTD and 77% YTD but down on Friday as RSI weakens (Genomics too frothy?). XLV healthcare is up 3.2% WTD and...
El Niño Tracking and Update, Fall 2026
This new blog will cover salient aspects of El Niño weather microclimate effects on cities, travel, recreation and business. 10/26/26…El Niño Updates : Coastal Flooding an Record Tides 10/29/26…Sea levels rising over one foot, ocean temp 9.1 degrees above normal. 10/29/26...
Trading Model for SMID Biotech Stocks: 2026 Recap
Trading Model for SMID Biotech Stocks- Outperfomed the Market in 2026 Our bullish call for Biotech Stocks was made in January 2026 after the JPMorgan Healthcare Conference. Our Trading Model selected a Portfolio of SMID Biotech stocks, Mutual Funds and ETFs to buy. Innovation with Precision...
SMID Biotech Stocks Stalled and are Lacking Momentum..Update-5….XENCOR!
10/27/26…….Update-5..Momentum continues as AI rolls on from Anthropic buzz with chip stock strength. SMH up over 3% and QQQs up over 1%. But biotechs get pulled along with tape and seasonality favors SMID biotechs thru early January. IBB up 1.63% in bullish technical zone at...
Biotech Stocks: Larger Caps are Favored until Momentum Returns…Update-3
Update-3 .10/20/26..3:45 p EDT SMID biotch rally with a green screen!…XLV momentum beats techs right now. RISK is on for healthcare and biotech. Update-2….1016/26- ….Tech wreck continues with focus on AI infrastructure funding and capital. Need to see if broadening of market...
